1. McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Eng. J. Med. 365, 2205–2219 (2011).

2. Wright, H. L., Moots, R. J. & Edwards, S. W. The multifactorial role of neutrophils in rheumatoid arthritis. Nat. Rev. Rheumatol. 10, 593–601 (2014).

3. Moots, R. J. & Naisbett-Groet, B. The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review. Rheumatology (Oxford) 51, 2252–2261 (2012).

4. Ding, J., Eyre, S. & Worthington, J. Genetics of RA susceptibility, what comes next? RMD Open 1, e000028 (2015).

5. Arandjelovic, S. & Ravichandran, K. S. Phagocytosis of apoptotic cells in homeostasis. Nat. Immunol. 16, 907–917 (2015).

6. Highton, J., Hessian, P. A., Kean, A. & Chin, M. Cell death by apoptosis is a feature of the rheumatoid nodule. Ann. Rheum. Dis. 62, 77–80 (2003).

7. Pope, R. M. Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat. Rev. Immunol. 2, 527–535 (2002).

8. Nagata, S., Hanayama, R. & Kawane, K. Autoimmunity and the clearance of dead cells. Cell 140, 619–630 (2010).

9. Elliott, M. R. & Ravichandran, K. S. The dynamics of apoptotic cell clearance. Dev. Cell. 38, 147–160 (2016).

10. Erwig, L. P. & Henson, P. M. Clearance of apoptotic cells by phagocytes. Cell Death Differ. 15, 243–250 (2008).

11. Gregory, C. D. & Pound, J. D. Microenvironmental influences of apoptosis in vivo and in vitro. Apoptosis 15, 1029–1049 (2010).

12. Miyanishi, M. et al. Identification of Tim4 as a phosphatidylserine receptor. Nature 450, 435–439 (2007).

13. Park, D. et al. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 450, 430–434 (2007).

14. Lemke, G. & Rothlin, C. V. Immunobiology of the TAM receptors. Nat. Rev. Immunol. 8, 327–336 (2008).

15. Savill, J. Recognition and phagocytosis of cells undergoing apoptosis. Br. Med. Bull. 53, 491–508 (1997).

16. Penberthy, K. K. & Ravichandran, K. S. Apoptotic cell recognition receptors and scavenger receptors. Immunol. Rev. 269, 44–59 (2016).

17. Brugnera, E. et al. Unconventional Rac-GEF activity is mediated through the Dock180–ELMO complex. Nat. Cell Biol. 4, 574–582 (2002).

18. Zhernakova, A. et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet. 7, e1002004 (2011).

19. Whitaker, J. W. et al. Integrative omics analysis of rheumatoid arthritis identifies non-obvious therapeutic targets. PLoS ONE 10, e0124254 (2015).

20. Grimsley, C. M. et al. Dock180 and ELMO1 proteins cooperate to promote evolutionarily conserved Rac-dependent cell migration. J. Biol. Chem. 279, 6087–6097 (2004).

21. Gumienny, T. L. et al. CED−12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell 107, 27–41 (2001).

22. Kouskoff, V. et al. Organ-specific disease provoked by systemic autoimmunity. Cell 87, 811–822 (1996).

23. Korganow, A. S. et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 10, 451–461 (1999).

24. Elliott, M. R. et al. Unexpected requirement for ELMO1 in clearance of apoptotic germ cells in vivo. Nature 467, 333–337 (2010).

25. Brand, D. D., Latham, K. A. & Rosloniec, E. F. Collagen-induced arthritis. Nat. Protoc. 2, 1269–1275 (2007).

26. Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R. & Forster, I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265–277 (1999).

27. Passegue, E., Wagner, E. F. & Weissman, I. L. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. Cell 119, 431–443 (2004).

28. Yona, S. et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38, 79–91 (2013).

29. Lewis, A. J., Seymour, C. W. & Rosengart, M. R. Current murine models of sepsis. Surg. Infect. (Larchmt) 17, 385–393 (2016).

30. Xiong, H. et al. Distinct contributions of neutrophils and CCR2+ monocytes to pulmonary clearance of different Klebsiella pneumoniae strains. Infect. Immun. 83, 3418–3427 (2015).

31. Pierson, E. R., Wagner, C. A. & Goverman, J. M. The contribution of neutrophils to CNS autoimmunity. Clin. Immunol. 189, 23–28 (2018).

32. Szklarczyk, D. et al. The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible. Nucleic Acids Res. 45, D362–D368 (2017).

33. Chou, R. C. et al. Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis. Immunity 33, 266–278 (2010).

34. Lammermann, T. et al. Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature 498, 371–375 (2013).

35. Mancardi, D. A. et al. Cutting edge: the murine high-affinity IgG receptor FcγRIV is sufficient for autoantibody-induced arthritis. J. Immunol. 186, 1899–1903 (2011).

36. Hornum, L. et al. C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid. PLoS ONE 12, e0189017 (2017).

37. Park-Min, K. H. et al. Negative regulation of osteoclast precursor differentiation by CD11b and β2 integrin-B-cell lymphoma 6 signaling. J. Bone Miner. Res. 28, 135–149 (2013).

38. Ji, H. et al. Arthritis critically dependent on innate immune system players. Immunity 16, 157–168 (2002).

39. Monach, P. A. et al. Neutrophils in a mouse model of autoantibody-mediated arthritis: critical producers of Fc receptor γ, the receptor for C5a, and lymphocyte function-associated antigen 1. Arthritis Rheum. 62, 753–764 (2010).

40. Wipke, B. T. & Allen, P. M. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J. Immunol. 167, 1601–1608 (2001).

41. Morgan, B. P., Griffiths, M., Khanom, H., Taylor, S. M. & Neal, J. W. Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats. Clin. Exp. Immunol. 138, 430–438 (2004).

42. Rittirsch, D. et al. Functional roles for C5a receptors in sepsis. Nat. Med. 14, 551–557 (2008).

43. Miyabe, Y. et al. Complement C5a receptor is the key initiator of neutrophil adhesion igniting immune complex-induced arthritis. Sci. Immunol. 2, eaaj2195 (2017).

44. Corr, M. & Crain, B. The role of FcγR signaling in the K/B x N serum transfer model of arthritis. J. Immunol. 169, 6604–6609 (2002).

45. Kiefer, F. et al. The Syk protein tyrosine kinase is essential for Fcγ receptor signaling in macrophages and neutrophils. Mol. Cell. Biol. 18, 4209–4220 (1998).

46. Ruzankina, Y. et al. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell 1, 113–126 (2007).

47. Matmati, M. et al. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat. Genet. 43, 908–912 (2011).

48. Hathaway, C. K. et al. High Elmo1 expression aggravates and low Elmo1 expression prevents diabetic nephropathy. Proc. Natl Acad. Sci. USA 113, 2218–2222 (2016).

49. Cooper, D. N. Functional intronic polymorphisms: buried treasure awaiting discovery within our genes. Hum. Genomics 4, 284–288 (2010).

50. Szanto, S., Gal, I., Gonda, A., Glant, T. T. & Mikecz, K. Expression of l-selectin, but not CD44, is required for early neutrophil extravasation in antigen-induced arthritis. J. Immunol. 172, 6723–6734 (2004).

51. Shrum, B. et al. A robust scoring system to evaluate sepsis severity in an animal model. BMC Res. Notes 7, 233 (2014).

52. Boyum, A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. Suppl. 97, 77–89 (1968).

53. Stohl, E. A., Criss, A. K. & Seifert, H. S. The transcriptome response of Neisseria gonorrhoeae to hydrogen peroxide reveals genes with previously uncharacterized roles in oxidative damage protection. Mol. Microbiol. 58, 520–532 (2005).

54. Collins, S. J., Ruscetti, F. W., Gallagher, R. E. & Gallo, R. C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl Acad. Sci. USA 75, 2458–2462 (1978).

55. Armaka, M., Gkretsi, V., Kontoyiannis, D. & Kollias, G. A standardized protocol for the isolation and culture of normal and arthritogenic murine synovial fibroblasts. Nat. Protoc. https://doi.org/10.1038/nprot.2009.102 (2009).

56. Alon, R. & Shulman, Z. Chemokine triggered integrin activation and actin remodeling events guiding lymphocyte migration across vascular barriers. Exp. Cell Res. 317, 632–641 (2011).

57. Bridges, D. & Moorhead, G. B. 14-3-3 proteins: a number of functions for a numbered protein. Sci. STKE 2005, re10 (2005).

58. Delclaux, C. et al. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am. J. Respir. Cell Mol. Biol. 14, 288–295 (1996).

59. Diaz-Alvarez, L. & Ortega, E. The many roles of galectin-3, a multifaceted molecule, in innate immune responses against pathogens. Mediators Inflamm. 2017, 9247574 (2017).

60. Germena, G., Volmering, S., Sohlbach, C. & Zarbock, A. Mutation in the CD45 inhibitory wedge modulates integrin activation and leukocyte recruitment during inflammation. J. Immunol. 194, 728–738 (2015).

61. Gittens, B. R., Bodkin, J. V., Nourshargh, S., Perretti, M. & Cooper, D. Galectin-3: a positive regulator of leukocyte recruitment in the inflamed microcirculation. J. Immunol. 198, 4458–4469 (2017).

62. Glennon-Alty, L., Hackett, A. P., Chapman, E. A. & Wright, H. L. Neutrophils and redox stress in the pathogenesis of autoimmune disease. Free Radic. Biol. Med. 125, 25–35 (2018).

63. Gough, R. E. & Goult, B. T. The tale of two talins—two isoforms to fine-tune integrin signalling. FEBS Lett. 592, 2108–2125 (2018).

64. Jin, J. et al. Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr. Biol. 14, 1436–1450 (2004).

65. Kletzien, R. F., Harris, P. K. & Foellmi, L. A. Glucose-6-phosphate dehydrogenase: a “housekeeping” enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress. FASEB J. 8, 174–181 (1994).

66. Oikonomou, K. G., Zachou, K. & Dalekos, G. N. α-actinin: a multidisciplinary protein with important role in B-cell driven autoimmunity. Autoimmun. Rev. 10, 389–396 (2011).

67. Sadik, C. D., Miyabe, Y., Sezin, T. & Luster, A. D. The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin. Semin. Immunol. 37, 21–29 (2018).

68. Sano, H. et al. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J. Immunol. 165, 2156–2164 (2000).

69. Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301–314 (1994).

70. Thomas, D. C. The phagocyte respiratory burst: historical perspectives and recent advances. Immunol. Lett. 192, 88–96 (2017).

71. Wyatt, E. et al. Regulation and cytoprotective role of hexokinase III. PLoS ONE 5, e13823 (2010).

72. Yang, X. et al. Structural basis for protein–protein interactions in the 14-3-3 protein family. Proc. Natl Acad. Sci. USA 103, 17237–17242 (2006).

73. Balakrishnan, L. et al. Differential proteomic analysis of synovial fluid from rheumatoid arthritis and osteoarthritis patients. Clin. Proteomics 11, 1 (2014).

74. Cui, J. et al. Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy. Arthritis Rheum. 62, 1849–1861 (2010).

75. de Rooy, D. P. et al. A genetic variant in the region of MMP-9 is associated with serum levels and progression of joint damage in rheumatoid arthritis. Ann. Rheum. Dis. 73, 1163–1169 (2014).

76. Gheita, T. A., Kenawy, S. A., El Sisi, R. W., Gheita, H. A. & Khalil, H. Subclinical reduced G6PD activity in rheumatoid arthritis and Sjogren’s syndrome patients: relation to clinical characteristics, disease activity and metabolic syndrome. Mod. Rheumatol. 24, 612–617 (2014).

77. Hu, C. Y., Chang, S. K., Wu, C. S., Tsai, W. I. & Hsu, P. N. Galectin-3 gene (LGALS3) +292C allele is a genetic predisposition factor for rheumatoid arthritis in Taiwan. Clin. Rheumatol. 30, 1227–1233 (2011).

78. Huang, R. Y., Huang, Q. C. & Burgering, B. M. Novel insight into the role of alpha-actinin-1 in rheumatoid arthritis. Discov. Med. 17, 75–80 (2014).

79. Maksymowych, W. P. & Marotta, A. 14-3-3eta: a novel biomarker platform for rheumatoid arthritis. Clin. Exp. Rheumatol. 32, S-35–S-39 (2014).

80. Tsuzaka, K., Itami, Y., Shinozaki, N. & Morishita, T. Plasma talin is a new diagnostic and monitoring marker for rheumatoid arthritis. Arthritis Rheum. 63, S134 (2011).

81. Warchol, T., Lianeri, M., Lacki, J. K., Olesinska, M. & Jagodzinski, P. P. ITGAM Arg77His is associated with disease susceptibility, arthritis, and renal symptoms in systemic lupus erythematosus patients from a sample of the Polish population. DNA Cell Biol. 30, 33–38 (2011).

82. Cottier, K. E., Fogle, E. M., Fox, D. A. & Ahmed, S. Noxa in rheumatic diseases: present understanding and future impact. Rheumatology (Oxford) 53, 1539–1546 (2014).

83. Cui, J. et al. Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis. PLoS Genet. 9, e1003394 (2013).

84. Elsby, L. M. et al. Functional evaluation of TNFAIP3 (A20) in rheumatoid arthritis. Clin. Exp. Rheumatol. 28, 708–714 (2010).

85. Howng, S. L. et al. Autoimmunity against hNinein, a human centrosomal protein, in patients with rheumatoid arthritis and systemic lupus erythematosus. Mol. Med. Rep. 4, 825–830 (2011).

86. Issuree, P. D. et al. iRHOM2 is a critical pathogenic mediator of inflammatory arthritis. J. Clin. Invest. 123, 928–932 (2013).

87. Jin, T., Tarkowski, A., Carmeliet, P. & Bokarewa, M. Urokinase, a constitutive component of the inflamed synovial fluid, induces arthritis. Arthritis. Res. Ther. 5, R9–R17 (2003).

88. Lopez, M. et al. Tumor necrosis factor and transforming growth factor β regulate clock genes by controlling the expression of the cold inducible RNA-binding protein (CIRBP). J. Biol. Chem. 289, 2736–2744 (2014).

89. Marotte, H. et al. Blocking of interferon regulatory factor 1 reduces tumor necrosis factor α-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein a: role of the nuclear interferon regulatory factor 1–NF-κB–c-jun complex. Arthritis Rheum. 63, 3253–3262 (2011).

90. Ohyama, K. et al. Serum immune complex containing thrombospondin-1: a novel biomarker for early rheumatoid arthritis. Ann. Rheum. Dis. 71, 1916–1917 (2012).

91. Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376–381 (2014).

92. Perlman, H. et al. Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1β-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis. Arthritis Rheum. 44, 21–30 (2001).

93. Rico, M. C. et al. Amelioration of inflammation, angiogenesis and CTGF expression in an arthritis model by a TSP1-derived peptide treatment. J. Cell. Physiol. 211, 504–512 (2007).

94. Yoo, I. S. et al. Serum and synovial fluid concentrations of cold-inducible RNA-binding protein in patients with rheumatoid arthritis. Int. J. Rheum. Dis. 21, 148–154 (2018).

95. Li, M. J. et al. GWASdb: a database for human genetic variants identified by genome-wide association studies. Nucleic Acids Res. 40, D1047–D1054 (2012).

96. Pletscher-Frankild, S., Palleja, A., Tsafou, K., Binder, J. X. & Jensen, L. J. DISEASES: text mining and data integration of disease-gene associations. Methods 74, 83–89 (2015).

97. Davis, A. P. et al. The comparative toxicogenomics database’s 10th year anniversary: update 2015. Nucleic Acids Res. 43, D914–D920 (2015).

98. Davis, A. P. et al. Comparative toxicogenomics database: a knowledgebase and discovery tool for chemical-gene-disease networks. Nucleic Acids Res. 37, D786–D792 (2009).

99. Eppig, J. T., Blake, J. A., Bult, C. J., Kadin, J. A. & Richardson, J. E. The Mouse Genome Database (MGD): facilitating mouse as a model for human biology and disease. Nucleic Acids Res. 43, D726–D736 (2015).